The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors for the continuation of S-1 adjuvant chemotherapy for gastric cancer analyzed from the JCOG1104 phase III trial.
 
Takanobu Yamada
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takaki Yoshikawa
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology
Research Funding - Lilly
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Hitoshi Katai
Honoraria - Johnson & Johnson
 
Akinori Takagane
No Relationships to Disclose
 
Shinji Okano
No Relationships to Disclose
 
Shin Teshima
No Relationships to Disclose
 
Hisayuki Matsushita
No Relationships to Disclose
 
Masahiro Goto
Honoraria - Daiichi Sankyo; Eisai; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma; Lilly; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical
 
Jun Hihara
No Relationships to Disclose
 
Yoshiyuki Kawashima
No Relationships to Disclose
 
Takeshi Omori
No Relationships to Disclose
 
Hisashi Shinohara
No Relationships to Disclose
 
Yasuhiro Yuasa
No Relationships to Disclose
 
Hiroshi Katayama
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Lilly; Nihonkayaku; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)
 
Takeshi Sano
Speakers' Bureau - Johnson & Johnson; Medtronic; Ono Pharmaceutical; Taiho Pharmaceutical
 
Mitsuru Sasako
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo; Lilly Japan; Merck; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Olympus